Respiratory
MART versus conventional ICS/LABA plus SABA: does switching actually change outcomes?
Across 19 papers published since 2022, a consistent picture emerges on MART versus conventional ICS/LABA plus SABA. The headline benefit is concentrated in exacerbation prevention - but the size of the gain depends heavily on baseline exacerbation risk.
Medicine Central3 months ago · 8 min read
